Our team looked back on some of the most thought-provoking insights from conversations with key decision-makers in oncology. In this podcast episode, we explore the challenges and opportunities faced by oncologists, payers, and pathway developers.
Read MoreNot only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.
Emma BijesseEasier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.
Cindy ChenAs Oncology pathway programs continue to become more prominent in the marketplace, manufacturers are being challenged to assess how influential a specific pathway is.
Daniel Buchenberger